Commitments and Contingencies (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Jun. 01, 2024 |
May 31, 2024 |
Jun. 01, 2023 |
May 31, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Other Commitments [Line Items] | |||||||
Insurance claim, errors and omissions | $ 150.0 | $ 100.0 | $ 150.0 | ||||
Insurance, deductible | 5.0 | ||||||
Loss contingencies | 4.9 | $ 6.4 | |||||
Loss contingencies, net of loss recoveries | 1.8 | 6.9 | $ 7.5 | ||||
Estimated loss contingencies | 0.3 | 0.2 | |||||
Insurance receivable for malpractice, current | 20.2 | $ 20.6 | |||||
General and Administrative Expense | |||||||
Other Commitments [Line Items] | |||||||
Loss contingencies | $ 2.5 | ||||||
Minimum | |||||||
Other Commitments [Line Items] | |||||||
Insurance, deductible | $ 2.5 | $ 2.5 | |||||
Maximum | |||||||
Other Commitments [Line Items] | |||||||
Insurance, deductible | $ 5.0 |
X | ||||||||||
- Definition The current portion of the amount receivable from insurance and similar arrangements for reimbursement and payment of malpractice claims and litigation costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of risk retained by the entity before the insurance arrangement begins to provide coverage. No definition available.
|
X | ||||||||||
- Definition Maximum coverage per malpractice claim provided by the insurance arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of costs associated with malpractice claims, including costs associated with litigating and settling claims, incurred during an accounting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|